Curtis Gale Oltmans
Insider Reports History
- Location
- Boulder, CO
- Signature
- /s/ Curt Oltmans
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Curtis Gale Oltmans:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Fulcrum Therapeutics, Inc. | Chief Legal Officer | Common Stock | 10,252 | $132,455 | $12.92 | 15 Dec 2025 | Direct |
| Fulcrum Therapeutics, Inc. | Chief Legal Officer | Stock Option (right to buy) | 170,000 | 02 Feb 2026 | Direct | ||
| AVENUE THERAPEUTICS, INC. | Director | Employee stock option (right to buy) | 30,000 | 23 Sep 2024 | Direct |
Insider Reports Filed by Curtis Gale Oltmans
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| FULC | Fulcrum Therapeutics, Inc. | 02 Feb 2026 | 1 | $0 | 4 | Chief Legal Officer | 04 Feb 2026, 16:10 |
| FULC | Fulcrum Therapeutics, Inc. | 15 Dec 2025 | 1 | -$44,600 | 4 | Chief Legal Officer | 17 Dec 2025, 16:10 |
| FULC | Fulcrum Therapeutics, Inc. | 24 Jan 2025 | 1 | $0 | 4 | Chief Legal Officer | 28 Jan 2025, 16:15 |
| ATXI | AVENUE THERAPEUTICS, INC. | 23 Sep 2024 | 1 | $0 | 4 | Director | 25 Sep 2024, 16:55 |
| FULC | Fulcrum Therapeutics, Inc. | 26 Jan 2024 | 1 | $0 | 4 | Chief Legal Officer | 30 Jan 2024, 21:00 |
| ATXI | AVENUE THERAPEUTICS, INC. | 30 Jun 2023 | 1 | $0 | 4 | Director | 05 Jul 2023, 16:07 |
| FULC | Fulcrum Therapeutics, Inc. | 26 Apr 2023 | 1 | $0 | 4 | Chief Legal Officer | 28 Apr 2023, 16:16 |
| FULC | Fulcrum Therapeutics, Inc. | 09 Feb 2023 | 1 | $0 | 4 | Chief Legal Officer | 13 Feb 2023, 15:15 |
| FULC | Fulcrum Therapeutics, Inc. | 09 Aug 2022 | 1 | $0 | 4 | Chief Legal Officer | 11 Aug 2022, 16:15 |
| FULC | Fulcrum Therapeutics, Inc. | 19 Jan 2022 | 1 | $0 | 4 | SVP, General Counsel | 21 Jan 2022, 15:15 |
| FULC | Fulcrum Therapeutics, Inc. | 31 Dec 2021 | 1 | $0 | 5 | SVP, General Counsel | 07 Jan 2022, 15:15 |
| ATXI | AVENUE THERAPEUTICS, INC. | 17 Dec 2021 | 1 | $0 | 4 | Director | 21 Dec 2021, 15:24 |
| FULC | Fulcrum Therapeutics, Inc. | 28 Jun 2021 | 1 | +$9,803 | 4 | SVP, General Counsel | 29 Jun 2021, 16:16 |
| ATXI | AVENUE THERAPEUTICS, INC. | 01 Apr 2021 | 0 | $0 | 3 | Director | 21 Dec 2021, 15:23 |